Stockreport

BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update [Yahoo! Finance]

BioNTech SE - American Depositary Shares  (BNTX) 
PDF Aiming for first oncology launch in 2026 and ten indication approvals by 2030 as part of BioNTech's strategy to develop combinatorial and synergistic therapeutic approa [Read more]